PACIRA BIOSCIENCES, INC.
Last · NasdaqGS$36.40+0.09 (+0.25%)close · yahoo · 15h ago
Market cap$1.45B39.9M sh
P/E · TTM104fwd 10.5 · eps 0.35
Beta0.25vs S&P 500
Div yield0.00%annual · TTM
52w range
$18.80$36.48
Volume2.3Msession
| Revenue | $369.8M |
|---|---|
| Operating income | $11.2M |
| Net income | $7.6M |
| Free cash flow | $79.1M |
| Operating margin | 3.0% |
| Net margin | 2.0% |
| Return on equity | 1.1% |
| Period | 2026 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.73
Est. revenue
182.9M
Earnings transcripts
Press & signals
- GlobeNewswire
Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
- GlobeNewswire
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags